Mon, December 5, 2011
Sun, December 4, 2011
Fri, December 2, 2011
Thu, December 1, 2011
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
00 a.m. EST
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
Mon, November 21, 2011
Sun, November 20, 2011

Teva to Present at the 23rd Annual Piper Jaffray Health Care Conference


//health-fitness.news-articles.net/content/2011/ .. annual-piper-jaffray-health-care-conference.html
Published in Health and Fitness on Monday, November 28th 2011 at 7:30 GMT by Market Wire   Print publication without navigation


JERUSALEM--([ ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the 23rd Annual Piper Jaffray Health Care Conference with William Marth, President & CEO, Teva Pharmaceuticals a" Americas, presenting on Wednesday, November 30, 2011 in New York.

What: Teva Presentation at the 23rd Annual Piper Jaffray Health Care Conference
Who: William Marth, President & CEO, Teva Pharmaceuticals - Americas
When: Wednesday, November 30, 2011 at 1:30 pm EST
Where:

[ http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TEVA.TA&item_id=4229173 ]

How: Live over the Internet a" log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Tevaas website.

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $16.1 billion in net sales in 2010.


Publication Contributing Sources